Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
Open accessThe DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Abstract
Staphylococcus aureus has long been recognized as an important pathogen in human disease. Due to an increasing number of infections caused by methicillin-resistant S. aureus (MRSA) strains, therapy has become problematic. Therefore, prevention of staphylococcal infections has become more important. Carriage of S. aureus appears to play a key role in the epidemiology and pathogenesis of infection. The ecological niches of S. aureus are the anterior nares. In healthy subjects, over time, three patterns of carriage can be distinguished: about 20% of people are persistent carriers, 60% are intermittent carriers, and approximately 20% almost never carry S. aureus. The molecular basis of the carrier state remains to be elucidated. In patients who repeatedly puncture the skin (e.g., hemodialysis or continuous ambulatory peritoneal dialysis [CAPD] patients and intravenous drug addicts) and patients with human immunodeficiency virus (HIV) infection, increased carriage rates are found. Carriage has been identified as an important risk factor for infection in patients undergoing surgery, those on hemodialysis or CAPD, those with HIV infection and AIDS, those with intravascular devices, and those colonized with MRSA. Elimination of carriage has been found to reduce the infection rates in surgical patients and those on hemodialysis and CAPD. Elimination of carriage appears to be an attractive preventive strategy in patients at risk. Further studies are needed to optimize this strategy and to define the groups at risk.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“People who misuse drugs have a higher rate of nasal or skin colonization with S. aureus than the general population (2, 14).”
From Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later (2008) · cites this paper as [14]
In the citing paper
“S. aureus nasal carriage, present in about 20% of the general population, has been identified as a risk factor for the subsequent development of community-acquired and nosocomial staphylococcal infections (14, 22).”
From Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later (2008) · cites this paper as [14]
In the citing paper
“S. aureus nasal carriage, present in about 20% of the general population, has been identified as a risk factor for the subsequent development of community-acquired and nosocomial staphylococcal infections (14, 22).”
From Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later (2008) · cites this paper as [14]
In the citing paper
“Carriage of S. aureus is a significant risk factor for nosocomial invasive infections by S. aureus (Kluytmans et al., 1997).”
From Nasal Microenvironments and Interspecific Interactions Influence Nasal Microbiota Complexity and S. aureus Carriage (2013) · cites this paper as Kluytmans et al., 1997
Citations
Cites
An overview of nosocomial infections, including the role of the microbiology laboratory
Emori, T. G., & Gaynes, R. P. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.428 · Cited by 1,286 · cited 1×
“In 1992, resistance had increased to nearly 8% (66).”
BackgroundThe Spectrum of Vasculitis: Clinical, Pathologic, Immunologic, and Therapeutic Considerations
FAUCI, A. S., HAYNES, B. F., & KATZ, P. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-5-660 · Cited by 1,196 · cited 1×
“Wegener’s granulomatosis is a systemic disease characterized by necrotizing granulomatous inflammation of the upper and lower respiratory tract in combination with vasculitis and focal necrotizing crescentic glomerulonephritis (52).”
BackgroundMSCRAMM-MEDIATED ADHERENCE OF MICROORGANISMS TO HOST TISSUES
Patti, J. M., Allen, B. L., McGavin, M. J., & Höök, M. (1994) · Annual Review of Microbiology · doi:10.1146/annurev.mi.48.100194.003101 · Cited by 1,191
Major trends in the microbial etiology of nosocomial infection
Schaberg, D. R., Culver, D. H., & Gaynes, R. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90346-y · Cited by 1,109 · cited 1×
“aureus is the second most prevalent organism causing intravascular device-associated bacteremia (111, 165).”
BackgroundMethicillin-ResistantStaphylococcus aureus in Europe
Voss, A., Milatovic, D., Wallrauch-Schwarz, C., Rosdahl, V. T., & Braveny, I. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02026127 · Cited by 801
Stegeman, C. A., Tervaert, J. W. C., Sluiter, W. J., Manson, W. L., de Jong, P. E., & Kallenberg, C. G. M. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-1-199401010-00003 · Cited by 729
Prevention and Control of Nosocomial Infections.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-5-791_4 · Cited by 719
Methicillin-Resistant Staphylococcus aureus in U.S. Hospitals, 1975–1991
Panlilio, A. L., Culver, D. H., Gaynes, R. P., Banerjee, S., Henderson, T. S., Tolson, J. S., Martone, W. J., & System, N. N. I. S. (1992) · Infection Control & Hospital Epidemiology · doi:10.1086/646432 · Cited by 657
Mulligan, M. E., Murray-Leisure, K. A., Ribner, B. S., Standiford, H. C., John, J. F., Korvick, J. A., Kauffman, C. A., & Yu, V. L. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90063-u · Cited by 641
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Cited by
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
The role of nasal carriage in Staphylococcus aureus infections
Wertheim, H. F., Melles, D. C., Vos, M. C., van Leeuwen, W., van Belkum, A., Verbrugh, H. A., & Nouwen, J. L. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70295-4 · Cited by 2,685
Self-citationDavid, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
“67 It is caused primarily by an acquired resistance from the VRE vanA gene, which alters the terminal sequence of cell wall precursors, making them poor substrates for vancomycin (52) and teicoplanin (55).”
BackgroundInfluentialStreptococcus pneumoniae colonisation: the key to pneumococcal disease
Bogaert, D., de Groot, R., & Hermans, P. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)00938-7 · Cited by 1,929
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
Lakhundi, S., & Zhang, K. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00020-18 · Cited by 1,637
“Increased use of FQs has been associated with abolition of sensitive strains from colonizing the nasal mucosa, predisposing it to be colonized by resistant strains (585).”
BackgroundMethicillin-resistant Staphylococcus aureus
Lee, A. S., de Lencastre, H., Garau, J., Kluytmans, J., Malhotra-Kumar, S., Peschel, A., & Harbarth, S. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.33 · Cited by 1,556
Self-citationAdhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus
Foster, T. J., Geoghegan, J. A., Ganesh, V. K., & Höök, M. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3161 · Cited by 1,533
Community-associated meticillin-resistant Staphylococcus aureus
DeLeo, F. R., Otto, M., Kreiswirth, B. N., & Chambers, H. F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61999-1 · Cited by 1,506
Antimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18535 · Cited by 1,445
Clinical relevance of the ESKAPE pathogens
Pendleton, J. N., Gorman, S. P., & Gilmore, B. F. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.12 · Cited by 1,423
Staphylococcus aureus biofilms: Properties, regulation, and roles in human disease
Archer, N. K., Mazaitis, M. J., Costerton, J. W., Leid, J. G., Powers, M. E., & Shirtliff, M. E. (2011) · Virulence · doi:10.4161/viru.2.5.17724 · Cited by 1,018
Iwase, T., Uehara, Y., Shinji, H., Tajima, A., Seo, H., Takada, K., Agata, T., & Mizunoe, Y. (2010) · Nature · doi:10.1038/nature09074 · Cited by 991
Pathogenesis of Methicillin‐Resistant Staphylococcus aureus Infection
Gordon, R. J., & Lowy, F. D. (2008) · Clinical Infectious Diseases · doi:10.1086/533591 · Cited by 961
“clearly increases the risk for subsequent infection [1, 2].”
BackgroundInternational consensus statement on allergy and rhinology: rhinosinusitis 2021
Orlandi, R. R., Kingdom, T. T., Smith, T. L., Bleier, B., DeConde, A., Luong, A. U., Poetker, D. M., Soler, Z., Welch, K. C., Wise, S. K., et al. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22741 · Cited by 959
Gorwitz, R. J., Kruszon‐Moran, D., McAllister, S. K., McQuillan, G., McDougal, L. K., Fosheim, G. E., Jensen, B. J., Killgore, G., Tenover, F. C., & Kuehnert, M. J. (2008) · The Journal of Infectious Diseases · doi:10.1086/533494 · Cited by 926
“[11].”
Allegranzi, B., Bischoff, P., de Jonge, S., Kubilay, N. Z., Zayed, B., Gomes, S. M., Abbas, M., Atema, J. J., Gans, S., van Rijen, M., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30398-x · Cited by 908
Self-citationWertheim, H. F., Vos, M. C., Ott, A., van Belkum, A., Voss, A., Kluytmans, J. A., van Keulen, P. H., Vandenbroucke-Grauls, C. M., Meester, M. H., & Verbrugh, H. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16897-9 · Cited by 892
Self-citationThe Challenge of Antibiotic Resistance
Levy, S. B. (1998) · Scientific American · doi:10.1038/scientificamerican0398-46 · Cited by 867
The Changing Microbial Epidemiology in Cystic Fibrosis
LiPuma, J. J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00068-09 · Cited by 806
Intranasal Mupirocin to Prevent Postoperative Staphylococcus aureus Infections
Perl, T. M., Cullen, J. J., Wenzel, R. P., Zimmerman, M. B., Pfaller, M. A., Sheppard, D., Twombley, J., French, P. P., & Herwaldt, L. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa003069 · Cited by 799
Peschel, A., Jack, R. W., Otto, M., Collins, L. V., Staubitz, P., Nicholson, G., Kalbacher, H., Nieuwenhuizen, W. F., Jung, G., Tarkowski, A., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1067 · Cited by 786
Staphylococcus aureus biofilms: recent developments in biofilm dispersal
Lister, J. L., & Horswill, A. R. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00178 · Cited by 706
“REVIEW ARTICLE published: 23 December 2014 doi: 10.3389/fcimb.2014.00178 Staphylococcus aureus biofilms: recent developments in biofilm dispersal”
BackgroundInfluentialPrevalence of Staphylococcus aureus Nasal Colonization in the United States, 2001–2002
Kuehnert, M. J., Kruszon‐Moran, D., Hill, H. A., McQuillan, G., McAllister, S. K., Fosheim, G., McDougal, L. K., Chaitram, J., Jensen, B., Fridkin, S. K., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/499632 · Cited by 659
“It is likely that some participants were transiently colonized and, thus, had variable potential to develop infection [10].”
BackgroundHospital Epidemiology and Infection Control in Acute-Care Settings
Sydnor, E. R. M., & Perl, T. M. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00027-10 · Cited by 652
“aureus causes a variety of infections ranging from skin and soft tissue infections to BSIs, pneumonia, meningitis, endocarditis, and toxic shock syndrome (27, 28, 170, 192, 250, 251, 347, 365, 369).”
BackgroundHassoun, A., Linden, P. K., & Friedman, B. (2017) · Critical Care · doi:10.1186/s13054-017-1801-3 · Cited by 604
“While the most common site of MRSA colonization is the anterior nares [45], S.”
BackgroundMasters, E. A., Trombetta, R. P., de Mesy Bentley, K. L., Boyce, B. F., Gill, A. L., Gill, S. R., Nishitani, K., Ishikawa, M., Morita, Y., Ito, H., et al. (2019) · Bone Research · doi:10.1038/s41413-019-0061-z · Cited by 575
“aureus is an extremely versatile opportunistic pathogen that can infect nearly every organ system in the human body causing life-threatening disease,(22) while maintaining the ability to asymptomatically colonize 20%–60% of individuals.(23) The invasive success of S.”
BackgroundSakr, A., Brégeon, F., Mège, J.-L., Rolain, J.-M., & Blin, O. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02419 · Cited by 555
“aureus infections (Kluytmans et al., 1997) in patients undergoing surgery (Perl et al.”
BackgroundDegradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus -Derived Proteinases
Sieprawska-Lupa, M., Mydel, P., Krawczyk, K., Wójcik, K., Puklo, M., Lupa, B., Suder, P., Silberring, J., Reed, M., Pohl, J., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4673-4679.2004 · Cited by 551
“Nasal carriage is an important risk factor for serious systemic and internal organ infections that have high morbidity and mortality, especially in those patients with a suppressed immune system, undergoing surgery, or with intravenous devices (18).”
BackgroundHealth-care workers: source, vector, or victim of MRSA?
Albrich, W. C., & Harbarth, S. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70097-5 · Cited by 526
Pinchuk, I. V., Beswick, E. J., & Reyes, V. E. (2010) · Toxins · doi:10.3390/toxins2082177 · Cited by 525
“aureus is persistent in 20% of the general population, while another 60% are intermittent carriers [1].”
BackgroundThe oral microbiome in health and disease and the potential impact on personalized dental medicine
Zarco, M., Vess, T., & Ginsburg, G. (2012) · Oral Diseases · doi:10.1111/j.1601-0825.2011.01851.x · Cited by 495
“In biofilm research, Veillonella species have also been found to enhance the growth of S. mutans (Klutymans et al, 1997).”
BackgroundRecognition of Staphylococcus aureus by the Innate Immune System
Fournier, B., & Philpott, D. J. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.3.521-540.2005 · Cited by 477
Staphylococcus aureus: new evidence for intracellular persistence
Garzoni, C., & Kelley, W. L. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2008.11.005 · Cited by 474
Corrigan, R. M., Abbott, J. C., Burhenne, H., Kaever, V., & Gründling, A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002217 · Cited by 463
“Staphylococcus aureus is a very prevalent human pathogen that permanently colonizes the nares and skin of approximately 20% of the population, while another 60% are colonized transiently [1].”
BackgroundA U.S. Population-Based Survey of Staphylococcus aureus Colonization
Graham, P. L., Lin, S. X., & Larson, E. L. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00006 · Cited by 452
Ellis, M. W., Hospenthal, D. R., Dooley, D. P., Gray, P. J., & Murray, C. K. (2004) · Clinical Infectious Diseases · doi:10.1086/423965 · Cited by 448
“Likewise, the prevalence of MSSA was 28%, which is in keeping with historically reported rates, implying that our sampling technique is valid [30].”
ResultReclassification of Staphylococcus aureus Nasal Carriage Types
van Belkum, A., Verkaik, N. J., de Vogel, C. P., Boelens, H. A., Verveer, J., Nouwen, J. L., Verbrugh, H. A., & Wertheim, H. F. L. (2009) · The Journal of Infectious Diseases · doi:10.1086/599119 · Cited by 427
“How nasal carriage is established and maintained is still largely unknown [1, 7].”
BackgroundSelf-citationThe Human Nasal Microbiota and Staphylococcus aureus Carriage
Frank, D. N., Feazel, L. M., Bessesen, M. T., Price, C. S., Janoff, E. N., & Pace, N. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010598 · Cited by 422
“aureus carriage is influenced by myriad host and environmental factors [24,25].”
BackgroundHuang, S. S., & Platt, R. (2003) · Clinical Infectious Diseases · doi:10.1086/345955 · Cited by 408
“Staphylococcus aureus is a human commensal organism carried in the nares of 30% of healthy adults [1].”
BackgroundOsteomyelitis and the role of biofilms in chronic infection
Brady, R. A., Leid, J. G., Calhoun, J. H., Costerton, J. W., & Shirtliff, M. E. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00357.x · Cited by 400
“Staphylococcus aureus is a normal commensal of the human nostrils; c. 20% of the population is consistently colonized with this bacterium, while 60% of the population are transient carriers (Kluytmans et al., 1997).”
BackgroundArmand-Lefevre, L., Ruimy, R., & Andremont, A. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1105.040866 · Cited by 397
“If these pig farmers had not been taken into account, the rate of nasal carriage in pig farmers would have been close to that found in controls (5).”
BackgroundResultInfection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update
Saiman, L., Siegel, J. D., LiPuma, J. J., Brown, R. F., Bryson, E. A., Chambers, M. J., Downer, V. S., Fliege, J., Hazle, L. A., Jain, M., et al. (2014) · Infection Control & Hospital Epidemiology · doi:10.1086/676882 · Cited by 387
Bacterial Competition for Human Nasal Cavity Colonization: Role of Staphylococcal agr Alleles
Lina, G., Boutite, F., Tristan, A., Bes, M., Etienne, J., & Vandenesch, F. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.1.18-23.2003 · Cited by 381
“aureus is an important cause of community- and hospital-acquired infections (14), and strategies for eliminating nasal carriage have been developed (11).”
BackgroundResultThe commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota
Krismer, B., Weidenmaier, C., Zipperer, A., & Peschel, A. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.104 · Cited by 375
Nasal Carriage of Staphylococcus aureus and Prevention of Nosocomial Infections
Kluytmans, J. A. J. W., & Wertheim, H. F. L. (2005) · Infection · doi:10.1007/s15010-005-4012-9 · Cited by 360
“aureus skin infections, liver dysfunction, and HIV [9,10].”
BackgroundInfluentialSelf-citationKateete, D. P., Kimani, C. N., Katabazi, F. A., Okeng, A., Okee, M. S., Nanteza, A., Joloba, M. L., & Najjuka, F. C. (2010) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-9-23 · Cited by 359
“Background Staphylococcus aureus is a ubiquitous commensal bacterium on human skins and anterior nares, but frequently causes severe infections in humans [1].”
BackgroundYan, M., Pamp, S. J., Fukuyama, J., Hwang, P. H., Cho, D.-Y., Holmes, S., & Relman, D. A. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.11.005 · Cited by 351
What determines nasal carriage of Staphylococcus aureus?
Peacock, S. J., de Silva, I., & Lowy, F. D. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02254-5 · Cited by 349
Normanno, G., La Salandra, G., Dambrosio, A., Quaglia, N. C., Corrente, M., Parisi, A., Santagada, G., Firinu, A., Crisetti, E., & Celano, G. V. (2007) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2006.10.049 · Cited by 349
“Despite its pathogenicity, S. aureus is also harboured in the nares of about 20–30% of healthy people, while about 60% of the population harbours the microorganism intermittently (Kluytsman et al., 1997).”
BackgroundKalmeijer, M. D., Coertjens, H., van Nieuwland‐Bollen, P. M., Bogaers‐Hofman, D., de Baere, G. A. J., Stuurman, A., van Belkum, A., & Kluytmans, J. A. J. W. (2002) · Clinical Infectious Diseases · doi:10.1086/341025 · Cited by 348
“aureus of ∼30% found in this study population falls within the range of nasal carriage rates reported in other studies [9].”
ResultSelf-citationThe role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation
Corrigan, R. M., Rigby, D., Handley, P., & Foster, T. J. (2007) · Microbiology · doi:10.1099/mic.0.2007/006676-0 · Cited by 341
“About 20 % of the human population carry S. aureus permanently in their noses and another 60 % of individuals are intermittent carriers (Kluytmans et al., 1997).”
BackgroundBacteriophage Endolysins as a Novel Class of Antibacterial Agents
Borysowski, J., Weber-Dąbrowska, B., & Górski, A. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100402 · Cited by 338
Cosgrove, K., Coutts, G., Jonsson, I.-M., Tarkowski, A., Kokai-Kun, J. F., Mond, J. J., & Foster, S. J. (2007) · Journal of Bacteriology · doi:10.1128/jb.01524-06 · Cited by 334
“Adherence is proposed to occur either through nonspecific hydrophobic interactions or via specific interactions between components of host cell membranes and surface proteins of S. aureus ( 28 ).”
BackgroundLindsay, J. A., Moore, C. E., Day, N. P., Peacock, S. J., Witney, A. A., Stabler, R. A., Husain, S. E., Butcher, P. D., & Hinds, J. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.2.669-676.2006 · Cited by 330
“Staphylococcus aureus is a persistent resident of the human nose in 20% of the population and intermittently carried by another 60% (16).”
BackgroundBacterial Infections in Drug Users
Gordon, R. J., & Lowy, F. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmra042823 · Cited by 329
Bloomfield, S. F., Aiello, A. E., Cookson, B., O'Boyle, C., & Larson, E. L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.07.001 · Cited by 328
“A study by Kluytmans et al suggests that S. aureus is carried as part of the normal body flora in up to 60% of the general population, 130 although a 2006 US study 131 suggests that the carriage rate is much less (31.6%).”
ResultInfluentialA Review of the Aetiology and Pathology of Leg Weakness in Broilers in Relation to Welfare
Bradshaw, R. H., Kirkden, R. D., & Broom, D. M. (2002) · Avian and Poultry Biology Reviews · doi:10.3184/147020602783698421 · Cited by 322
“Bacterial interference has been used as a successful strategy to prevent staphylococcal infection in human nurseries (Kluytmans et al 1997) and turkeys (Jensen et al 1987).”
Antibiotics, Resistome and Resistance Mechanisms: A Bacterial Perspective
Sultan, I., Rahman, S., Jan, A. T., Siddiqui, M. T., Mondal, A. H., & Haq, Q. M. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02066 · Cited by 320
Foxman, B. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.2.103 · Cited by 319
Miller, L. G., & Diep, B. A. (2008) · Clinical Infectious Diseases · doi:10.1086/526773 · Cited by 318
Sung, J. M.-L., Lloyd, D. H., & Lindsay, J. A. (2008) · Microbiology · doi:10.1099/mic.0.2007/015289-0 · Cited by 302
“In humans, Staphylococcus aureus is a persistent resident of the human nose in 20 % of the healthy population, and intermittently carried by another 60 % (Kluytmans et al., 1997).”
BackgroundNoskin, G. A., Rubin, R. J., Schentag, J. J., Kluytmans, J., Hedblom, E. C., Smulders, M., Lapetina, E., & Gemmen, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.15.1756 · Cited by 299
“Other techniques for eliminating nasal carriage of S aureus include the administration of systemic antibiotics, which has had disappointing results, and the active colonization of patients with the 502A strain of S aureus, which can prevent colonization by more virulent types of the organism but can still cause seriou…”
BackgroundSelf-citationRegev-Yochay, G. (2004) · JAMA · doi:10.1001/jama.292.6.716 · Cited by 297
“Staphylococcus aureus is carried by 10% to 35% of children(5-7) and by approximately 35% of the general adult population.(3) Staphylococcus aureus is carried most consistently in the nares.”
BackgroundInnate Antimicrobial Activity of Nasal Secretions
Cole, A. M., Dewan, P., & Ganz, T. (1999) · Infection and Immunity · doi:10.1128/iai.67.7.3267-3275.1999 · Cited by 292
“5%) is within the expected frequency based on previous estimates of carriage rates of 8 to 18% (18).”
BackgroundKim, D. H., Spencer, M., Davidson, S. M., Li, L., Shaw, J. D., Gulczynski, D., Hunter, D. J., Martha, J. F., Miley, G. B., Parazin, S. J., et al. (2010) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.i.01050 · Cited by 290
“A surgical site infection was considered to be present if one of the following findings was noted within thirty days after the operation: (1) the wound drained purulent material, (2) the wound drained serosanguineous material, the edges of the wound and surrounding tissues were erythematous, and the wound culture yiel…”
BackgroundKalmeijer, M. D., Nieuwland-Bollen, E. V., Bogaers-Hofman, D., Baere, G. A. J. D., & Kluytmans, J. A. J. W. (2000) · Infection Control & Hospital Epidemiology · doi:10.1086/501763 · Cited by 289
“1%) was found, based on many studies over the years 1934 to 1994.(24) Therefore, the carriage rate in the current study was within the expected range.”
BackgroundSelf-citationMupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers
van Rijen, M., Bonten, M., Wenzel, R., & Kluytmans, J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006216.pub2 · Cited by 286
Self-citationHarbarth, S., Dharan, S., Liassine, N., Herrault, P., Auckenthaler, R., & Pittet, D. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1412 · Cited by 286
“aureus (MRSA) is an essential step in invasive MRSA infections and plays a decisive role in the dissemination of these microorganisms (18, 31).”
BackgroundBacteria from Animals as a Pool of Antimicrobial Resistance Genes
Argudín, M., Deplano, A., Meghraoui, A., Dodémont, M., Heinrichs, A., Denis, O., Nonhoff, C., & Roisin, S. (2017) · Antibiotics · doi:10.3390/antibiotics6020012 · Cited by 283
Gorwitz, R. J., Jernigan, D. B., Powers, J. H., & Jernigan, J. A. (2006) · Cited by 284
Meticillin-resistant Staphylococcus aureus in animals: A review
Leonard, F. C., & Markey, B. K. (2008) · The Veterinary Journal · doi:10.1016/j.tvjl.2006.11.008 · Cited by 282
“In a comprehensive review of published cross-sectional surveys Kluytmans et al. (1997) reported a mean carriage rate of 37.2%.”
BackgroundInfluentialCommensal Staphylococci Influence Staphylococcus aureus Skin Colonization and Disease
Parlet, C. P., Brown, M. M., & Horswill, A. R. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.01.008 · Cited by 276
“aureus is the anterior nares [35], and many of the initial direct microbe interaction studies with S.”
BackgroundRapid single cell detection of Staphylococcus aureus by aptamer-conjugated gold nanoparticles
Chang, Y.-C., Yang, C.-Y., Sun, R.-L., Cheng, Y.-F., Kao, W.-C., & Yang, P.-C. (2013) · Scientific Reports · doi:10.1038/srep01863 · Cited by 275
Creech, C. B., Kernodle, D. S., Alsentzer, A., Wilson, C., & Edwards, K. M. (2005) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000168746.62226.a4 · Cited by 267
Acton, D. S., Tempelmans Plat-Sinnige, M. J., van Wamel, W., de Groot, N., & van Belkum, A. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0602-7 · Cited by 263
“They found that 10% had persistent carriage, 63% had intermittent carriage, and 27% were non-carriers, in agreement with nasal carriage patterns [1].”
BackgroundPlata, K., Rosato, A. E., & Wegrzyn, G. (2009) · Acta Biochimica Polonica · doi:10.18388/abp.2009_2491 · Cited by 259
“Colonization significantly increases the risk of infections since it provides a reservoir of the pathogen from which bacteria are introduced when host defense is compromised (Kluytmans et al., 1997).”
BackgroundDecolonization in Prevention of Health Care-Associated Infections
Septimus, E. J., & Schweizer, M. L. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00049-15 · Cited by 259
“Close quarters, open wounds, devices, and suboptimal health care worker hand hygiene and environmental cleaning are risk factors for exogenous infections (33, 34).”
BackgroundStaphylococcus aureus: Determinants of human carriage
Sollid, J. U. E., Furberg, A. S., Hanssen, A. M., & Johannessen, M. (2014) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.03.020 · Cited by 257
“aureus nasal carriage in the adult population (Wertheim et al., 2004; Kluytmans et al., 1997), supporting a role of living conditions, crowding and hygiene.”
BackgroundZecconi, A., & Scali, F. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.01.004 · Cited by 256
Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus
Melles, D. C., Gorkink, R. F. J., Boelens, H. A. M., Snijders, S. V., Peeters, J. K., Moorhouse, M. J., van der Spek, P. J., van Leeuwen, W. B., Simons, G., Verbrugh, H. A., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423083 · Cited by 255
Self-citationStaphylococcal response to oxidative stress
Gaupp, R., Ledala, N., & Somerville, G. A. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00033 · Cited by 253
“In addition, S. aureus is a prevalent cause of infections due to the fact that 20–30% of humans carry S. aureus in their anterior nares (Kluytmans et al., 1997; von Eiff et al., 2001; Wertheim et al., 2005).”
BackgroundInfluentialCo-evolutionary aspects of human colonisation and infection by Staphylococcus aureus
VANBELKUM, A., MELLES, D., NOUWEN, J., VANLEEUWEN, W., VANWAMEL, W., VOS, M., WERTHEIM, H., & VERBRUGH, H. (2009) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2008.09.012 · Cited by 251
“Regular and long-term puncture of the skin by needles and/or intravascular catheters seems to be the common factor in these groups (Kluytmans et al., 1997).”
BackgroundSelf-citationKluytmans, J. A. J. W., Mouton, J. W., VandenBergh, M. F. Q., Manders, M.-J. A. A. J., Maat, A. P. W. M., Wagenvoort, J. H. T., Michel, M. F., & Verbrugh, H. A. (1996) · Infection Control & Hospital Epidemiology · doi:10.1086/647236 · Cited by 250
Self-citationGilot, P., Lina, G., Cochard, T., & Poutrel, B. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.11.4060-4067.2002 · Cited by 250
“The presence of this bacterium in raw milk represents a risk for human health and causes serious economic losses to milk producers around the world (17, 27).”
BackgroundBakhsheshian, J., Dahdaleh, N. S., Lam, S. K., Savage, J. W., & Smith, Z. A. (2015) · World Neurosurgery · doi:10.1016/j.wneu.2014.12.033 · Cited by 248
Brown, A. F., Leech, J. M., Rogers, T. R., & McLoughlin, R. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00507 · Cited by 246
Clement, S., Vaudaux, P., Francois, P., Schrenzel, J., Huggler, E., Kampf, S., Chaponnier, C., Lew, D., & Lacroix, J. (2005) · The Journal of Infectious Diseases · doi:10.1086/432735 · Cited by 245
“[2] or nasal mucus secretions [9], were extensively stud-”
BackgroundCommunity‐Associated Methicillin‐Resistant Staphylococcus aureus
Weber, J. T. (2005) · Clinical Infectious Diseases · doi:10.1086/430788 · Cited by 244
Paharik, A. E., Parlet, C. P., Chung, N., Todd, D. A., Rodriguez, E. I., Van Dyke, M. J., Cech, N. B., & Horswill, A. R. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.11.001 · Cited by 244
“Often termed a pathobiont, S. aureus is both a potent bacterial pathogen and a common constituent of human cutaneous and mucosal flora that persistently colonizes 20% of the healthy adult population (Kluytmans et al., 1997).”
Graham, D. W., Bergeron, G., Bourassa, M. W., Dickson, J., Gomes, F., Howe, A., Kahn, L. H., Morley, P. S., Scott, H. M., Simjee, S., et al. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14036 · Cited by 242
Fux, C. A., Wilson, S., & Stoodley, P. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.14.4486-4491.2004 · Cited by 240
“Roughly 40% of the general population are colonized with Staphylococcus aureus and therefore carry an increased risk for infections associated with surgery, dialysis, or intravascular devices (11).”
BackgroundPost-traumatic Infectious Endophthalmitis
Bhagat, N., Nagori, S., & Zarbin, M. (2011) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2010.09.002 · Cited by 240
Throat Swabs Are Necessary to Reliably Detect Carriers of Staphylococcus aureus
Mertz, D., Frei, R., Jaussi, B., Tietz, A., Stebler, C., Fluckiger, U., & Widmer, A. F. (2007) · Clinical Infectious Diseases · doi:10.1086/520016 · Cited by 237
“aureus in the nose appears to play a key role in the epidemiology and pathogenesis of infection and is associated with an increased risk of infectious complications after surgery in patients with end-stage renal failure and in those with intravascular devices [1, 6].”
BackgroundMoellering, R. C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr437 · Cited by 236
Manian, F. A. (2003) · Clinical Infectious Diseases · doi:10.1086/344772 · Cited by 234
“aureus [18], investigation into asymptomatic MRSA carriage in canine household members may need serious consideration for patients with recurrent community-acquired MRSA infections.”
BackgroundVandenBergh, M. F. Q., Yzerman, E. P. F., van Belkum, A., Boelens, H. A. M., Sijmons, M., & Verbrugh, H. A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.10.3133-3140.1999 · Cited by 233
“Staphylococcus aureus nasal carriage has been extensively studied in patients and healthy individuals (22, 54).”
BackgroundSelf-citationDaniel, A., Euler, C., Collin, M., Chahales, P., Gorelick, K. J., & Fischetti, V. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01625-09 · Cited by 233
Rashel, M., Uchiyama, J., Ujihara, T., Uehara, Y., Kuramoto, S., Sugihara, S., Yagyu, K., Muraoka, A., Sugai, M., Hiramatsu, K., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/521305 · Cited by 232
Nouwen, J. L., Ott, A., Kluytmans-Vandenbergh, M. F. Q., Boelens, H. A. M., Hofman, A., van Belkum, A., & Verbrugh, H. A. (2004) · Clinical Infectious Diseases · doi:10.1086/423376 · Cited by 231
“aureus nasal carriage patterns can be discerned: persistent carriage, intermittent carriage, and noncarriage [11–22].”
BackgroundSelf-citation
Metadata
- Authors
- Kluytmans, J., van Belkum, A., & Verbrugh, H.
- Affiliations
- Ignatius Hospital (NL)
- Ignatius Hospital Breda, The Netherlands.
- ORCID
- Kluytmans, J
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1997-07
- Volume
- 10
- Issue
- 3
- Pages
- 505-520
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC172932
- OpenAlex
- W2111113492
- Cited by
- 2,595
- References
- 217
- Citations by year
- 2026: 38 · 2025: 58 · 2024: 77 · 2023: 73 · 2022: 103 · 2021: 92 · 2020: 99 · 2019: 126 · 2018: 116 · 2017: 152 · 2016: 166 · 2015: 137 · 2014: 162 · 2013: 179 · 2012: 134
- FWCI
- 14.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Otolaryngology and Infectious Diseases
- Keywords
- Staphylococcus aureus, nasal carriage, methicillin-resistant Staphylococcus aureus, persistent carriage, infection risk factors, hemodialysis, continuous ambulatory peritoneal dialysis, people who inject drugs, HIV infection, surgical patients, intravascular devices, infection control
- MeSH terms
- Bacterial Adhesion, Carrier State, Endothelium, Endothelium, Corneal, Epithelium, Renal Dialysis, Humans, Peritoneal Dialysis, Continuous Ambulatory, Risk Factors, Staphylococcal Infections, Staphylococcus aureus, Surgical Wound Infection, HIV Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.